Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Medpace Holdings, Inc. (MEDP)
|
Add to portfolio |
|
|
|
| Price: |
$214.31
| | Metrics |
| OS: |
31.0
|
M
| |
78
|
% ROE
|
| Market cap: |
$6.64
|
B
| |
|
|
|
Net cash:
|
$42.6
|
M
| |
$1.37
|
per share
|
|
EV:
|
$6.6
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
$253
|
M
| |
26.1
|
x EV/EBIT
|
| EPS |
$6.30
| |
34.0
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-05-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 1,142.4 | 1,142.4 | 925.9 | 925.9 | 861.0 | 704.6 | 436.2 | 421.6 |
| Revenue growth | 23.4% | 23.4% | 7.5% | | 22.2% | 61.5% | 3.5% | 17.4% |
| Cost of goods sold | 814.2 | 814.2 | 647.2 | 647.2 | 615.3 | 489.1 | 261.5 | 448.0 |
| Gross profit | 328.2 | 328.2 | 278.7 | 278.7 | 245.7 | 215.5 | 174.7 | -26.4 |
| Gross margin | 28.7% | 28.7% | 30.1% | 30.1% | 28.5% | 30.6% | 40.1% | -6.3% |
| Selling, general and administrative | 129.5 | 108.4 | 111.7 | 92.2 | 118.4 | 75.7 | 63.4 | 61.5 |
| EBITA | 207.6 | 203.7 | 176.4 | 174.9 | 141.4 | 130.6 | 102.8 | 103.2 |
| EBITA margin | 18.2% | 17.8% | 19.0% | 18.9% | 16.4% | 18.5% | 23.6% | 24.5% |
| Amortization of intangibles | 5.1 | 5.1 | 7.9 | 7.9 | 14.8 | 29.6 | 37.9 | 50.7 |
| EBIT | 202.5 | 198.6 | 168.5 | 167.0 | 126.6 | 101.0 | 64.9 | 52.5 |
| EBIT margin | 17.7% | 17.4% | 18.2% | 18.0% | 14.7% | 14.3% | 14.9% | 12.5% |
| Pre-tax income | 201.9 | 201.9 | 168.5 | 168.5 | 124.8 | 94.0 | 56.9 | 22.0 |
| Income taxes | 20.0 | 20.0 | 23.1 | 23.1 | 24.4 | 20.8 | 17.8 | 8.5 |
| Tax rate | 9.9% | 9.9% | 13.7% | 13.7% | 19.5% | 22.1% | 31.3% | 38.9% |
| Net income | 181.8 | 181.8 | 145.4 | 145.4 | 100.4 | 73.2 | 39.1 | 13.4 |
| Net margin | 15.9% | 15.9% | 15.7% | 15.7% | 11.7% | 10.4% | 9.0% | 3.2% |
| |
| Diluted EPS | $4.82 | $4.82 | $3.86 | $3.86 | $2.67 | $1.98 | $0.98 | $0.37 |
| Shares outstanding (diluted) | 37.7 | 37.7 | 37.7 | 37.7 | 37.6 | 36.9 | 39.8 | 36.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|